Hepatitis B Surface Antigen Adr Recombinant Protein

The hepatitis B virus is an important cause of acute and chronic liver disease. It is also the most common form of parenterally transmitted viral hepatitis. The virus is estimated to affect some 350 million people worldwide. Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries.

Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and infection with HBV is usually more serious than infection with hepatitis A virus. In some individuals the infection is not cleared and followed by persistent intracellular viral carriage that can lead to the development of hepatocelular carcinomas. There are currently 400 million HBV carriers worldwide making HBV one of the most common human pathogens.
The capsid of a virus has different surface proteins from the rest of the virus. The antigen is a protein that binds specifically on one of these surfce proteins. It is commonly referred to as the Australian Antigen. Recombinant HBsAg adr full length monomeric protein contains 227 amino acids of the S-gene with a molecular weight of 24 kD. Small amounts of dimer and trimer forms also exist in the solution.

Small volumes of Hepatitis B Surface Antigen adr recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS636383 is a recombinant protein targeting Hepatitis B Surface Antigen adr. Also known as Hepatitis B Surface Antigen adr, Recombinant (HBsAg adr). Host: Saccharomyces cerevisae.